Table 2.
PDAC cohort | |
---|---|
Peritumoral tissues (n=91) | HHLA2 positivity rate |
Normal and inflammed duct cells | 9/91(9.89%) |
Acinar cells | 1/91(1.09%) |
Islet cells | 3/91(3.29%) |
PanIN (n=20) | 19/20(95%) |
Adenocarcinoma (n=92) | 71/92(77.17%) |
PDAC cohort | |
---|---|
Peritumoral tissues (n=91) | HHLA2 positivity rate |
Normal and inflammed duct cells | 9/91(9.89%) |
Acinar cells | 1/91(1.09%) |
Islet cells | 3/91(3.29%) |
PanIN (n=20) | 19/20(95%) |
Adenocarcinoma (n=92) | 71/92(77.17%) |